CN104918620B - 作为二酰基甘油酰基转移酶抑制剂的化合物 - Google Patents

作为二酰基甘油酰基转移酶抑制剂的化合物 Download PDF

Info

Publication number
CN104918620B
CN104918620B CN201380069807.4A CN201380069807A CN104918620B CN 104918620 B CN104918620 B CN 104918620B CN 201380069807 A CN201380069807 A CN 201380069807A CN 104918620 B CN104918620 B CN 104918620B
Authority
CN
China
Prior art keywords
bases
amino
dihydro
oxygen azepine
indoles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201380069807.4A
Other languages
English (en)
Chinese (zh)
Other versions
CN104918620A (zh
Inventor
M.张
R.S.坦吉拉拉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline LLC
Original Assignee
GlaxoSmithKline LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline LLC filed Critical GlaxoSmithKline LLC
Publication of CN104918620A publication Critical patent/CN104918620A/zh
Application granted granted Critical
Publication of CN104918620B publication Critical patent/CN104918620B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Child & Adolescent Psychology (AREA)
  • Virology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CN201380069807.4A 2012-11-23 2013-11-22 作为二酰基甘油酰基转移酶抑制剂的化合物 Expired - Fee Related CN104918620B (zh)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
IN3593/DEL/2012 2012-11-23
IN3593DE2012 2012-11-23
IN750DE2013 2013-03-14
IN750/DEL/2013 2013-03-14
IN3172DE2013 2013-10-25
IN3172/DEL/2013 2013-10-25
PCT/US2013/071376 WO2014081994A1 (en) 2012-11-23 2013-11-22 Novel compounds as diacylglycerol acyltransferase inhibitors

Publications (2)

Publication Number Publication Date
CN104918620A CN104918620A (zh) 2015-09-16
CN104918620B true CN104918620B (zh) 2017-06-09

Family

ID=50776577

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201380069807.4A Expired - Fee Related CN104918620B (zh) 2012-11-23 2013-11-22 作为二酰基甘油酰基转移酶抑制剂的化合物

Country Status (31)

Country Link
US (1) US20150322082A1 (cg-RX-API-DMAC10.html)
EP (2) EP3492474B1 (cg-RX-API-DMAC10.html)
JP (1) JP6279600B2 (cg-RX-API-DMAC10.html)
KR (1) KR102176463B1 (cg-RX-API-DMAC10.html)
CN (1) CN104918620B (cg-RX-API-DMAC10.html)
AU (1) AU2013347843B2 (cg-RX-API-DMAC10.html)
BR (1) BR112015011982A8 (cg-RX-API-DMAC10.html)
CA (1) CA2892304C (cg-RX-API-DMAC10.html)
CL (1) CL2015001397A1 (cg-RX-API-DMAC10.html)
CY (1) CY1121426T1 (cg-RX-API-DMAC10.html)
DK (1) DK2922551T3 (cg-RX-API-DMAC10.html)
EA (1) EA031114B1 (cg-RX-API-DMAC10.html)
ES (1) ES2708626T3 (cg-RX-API-DMAC10.html)
HR (1) HRP20190099T1 (cg-RX-API-DMAC10.html)
HU (1) HUE042483T2 (cg-RX-API-DMAC10.html)
IL (1) IL238835B (cg-RX-API-DMAC10.html)
LT (1) LT2922551T (cg-RX-API-DMAC10.html)
ME (1) ME03315B (cg-RX-API-DMAC10.html)
MX (1) MX363484B (cg-RX-API-DMAC10.html)
NZ (1) NZ630436A (cg-RX-API-DMAC10.html)
PE (1) PE20150967A1 (cg-RX-API-DMAC10.html)
PH (1) PH12015501109A1 (cg-RX-API-DMAC10.html)
PL (1) PL2922551T3 (cg-RX-API-DMAC10.html)
PT (1) PT2922551T (cg-RX-API-DMAC10.html)
RS (1) RS58539B1 (cg-RX-API-DMAC10.html)
SG (1) SG11201503761WA (cg-RX-API-DMAC10.html)
SI (1) SI2922551T1 (cg-RX-API-DMAC10.html)
SM (1) SMT201900230T1 (cg-RX-API-DMAC10.html)
UA (1) UA115079C2 (cg-RX-API-DMAC10.html)
WO (1) WO2014081994A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA201503304B (cg-RX-API-DMAC10.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018052818A (ja) * 2015-01-28 2018-04-05 武田薬品工業株式会社 スルホンアミド化合物
CN109963561A (zh) * 2016-11-18 2019-07-02 默沙东公司 可用作二酰基甘油酯o-酰基转移酶2的抑制剂的吲哚衍生物

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090076275A1 (en) * 2007-09-19 2009-03-19 David Robert Bolin Diacylglycerol acyltransferase inhibitors
US20100204119A1 (en) * 2009-02-02 2010-08-12 Pfizer Inc 4-amino-5-oxo-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-6(5h)-yl phenyl derivatives

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100795462B1 (ko) * 2006-09-27 2008-01-16 한국생명공학연구원 인돌 유도체, 이의 제조방법 및 이를 유효성분으로함유하는 대사성 질환 예방 및 치료용 약학적 조성물
US20090036425A1 (en) * 2007-08-02 2009-02-05 Pfizer Inc Substituted bicyclolactam compounds
AR066169A1 (es) * 2007-09-28 2009-07-29 Novartis Ag Derivados de benzo-imidazoles, utiles para trastornos asociados con la actividad de dgat
US8324385B2 (en) * 2008-10-30 2012-12-04 Madrigal Pharmaceuticals, Inc. Diacylglycerol acyltransferase inhibitors
WO2011121350A1 (en) 2010-04-01 2011-10-06 Astrazeneca Ab 4 -amino -7,8- dihydropyrimido [5, 4 - f] [1, 4] oxazepin- 5 ( 6h) - one based dgat1 inhibitors
KR101919080B1 (ko) * 2011-05-20 2018-11-16 글락소스미스클라인 인털렉츄얼 프로퍼티 (넘버 2) 리미티드 디아실글리세롤 아실트랜스퍼라제 억제제로서의 신규 화합물

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090076275A1 (en) * 2007-09-19 2009-03-19 David Robert Bolin Diacylglycerol acyltransferase inhibitors
US20100204119A1 (en) * 2009-02-02 2010-08-12 Pfizer Inc 4-amino-5-oxo-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-6(5h)-yl phenyl derivatives

Also Published As

Publication number Publication date
EP3492474A1 (en) 2019-06-05
EP2922551B1 (en) 2018-10-31
LT2922551T (lt) 2019-02-11
CN104918620A (zh) 2015-09-16
DK2922551T3 (en) 2019-02-18
HK1214757A1 (en) 2016-08-05
IL238835B (en) 2019-07-31
CA2892304C (en) 2021-03-30
EP2922551A1 (en) 2015-09-30
IL238835A0 (en) 2015-06-30
ME03315B (me) 2019-10-20
ZA201503304B (en) 2016-05-25
SG11201503761WA (en) 2015-06-29
JP2016500109A (ja) 2016-01-07
US20150322082A1 (en) 2015-11-12
BR112015011982A2 (pt) 2017-07-11
JP6279600B2 (ja) 2018-02-14
HUE042483T2 (hu) 2019-06-28
SI2922551T1 (sl) 2019-05-31
CL2015001397A1 (es) 2015-08-28
KR102176463B1 (ko) 2020-11-09
MX363484B (es) 2019-03-21
ES2708626T3 (es) 2019-04-10
EP2922551A4 (en) 2016-04-27
KR20150087852A (ko) 2015-07-30
SMT201900230T1 (it) 2019-07-11
AU2013347843B2 (en) 2016-06-16
WO2014081994A1 (en) 2014-05-30
PH12015501109B1 (en) 2015-08-17
MX2015006533A (es) 2015-08-06
PH12015501109A1 (en) 2015-08-17
HRP20190099T1 (hr) 2019-04-19
AU2013347843A1 (en) 2015-05-28
NZ630436A (en) 2016-08-26
PE20150967A1 (es) 2015-06-25
UA115079C2 (uk) 2017-09-11
PT2922551T (pt) 2019-02-04
EA031114B1 (ru) 2018-11-30
BR112015011982A8 (pt) 2019-10-08
CY1121426T1 (el) 2020-05-29
PL2922551T3 (pl) 2019-06-28
EA201590982A1 (ru) 2015-11-30
CA2892304A1 (en) 2014-05-30
EP3492474B1 (en) 2021-08-11
RS58539B1 (sr) 2019-04-30

Similar Documents

Publication Publication Date Title
KR102666727B1 (ko) 방향족 비닐 또는 방향족 에틸계 유도체, 그의 제조방법, 중간체, 약물조성물 및 용도
US10385066B2 (en) Compounds as diacylglycerol acyltransferase inhibitors
CN103703009B (zh) 作为二酰基甘油酰基转移酶抑制剂的新化合物
EA017029B1 (ru) Антагонисты рецептора гонадотропин-рилизинг-фактора и способы их применения
TW201625581A (zh) 側氧雜環衍生物
AU2023298566A1 (en) 3,4-dihydroquinolin-2(1h)-one compound
KR20220004036A (ko) 소분자 pd-1/pd-l1 억제제, 이와 pd-l1 항체의 약학 조성물 및 이의 용도
WO2019242689A1 (zh) 一种氰基取代吡啶及氰基取代嘧啶类化合物、制备方法及其应用
KR102526281B1 (ko) 옥사지노-퀴나졸린 및 옥사지노-퀴놀린형 화합물, 이의 제조방법 및 용도
CN104869997B (zh) 作为二酰基甘油酰基转移酶抑制剂的新型化合物
CN104918620A (zh) 作为二酰基甘油酰基转移酶抑制剂的新化合物
WO2022194265A1 (zh) 一种喹唑啉类化合物、组合物及其应用
HK1214757B (en) Novel compounds as diacylglycerol acyltransferase inhibitors
HK1164060A (en) Cyclopropane amides and analogs exhibiting anti-cancer and anti-proliferative activities

Legal Events

Date Code Title Description
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20170609

Termination date: 20211122